1332 results
Severe symptomatic aortic stenosis in a "no access for TAVI" patient and an "unexpected" toll for balloon valvotomy
18 Oct 2023
An 88-year-old lady was admitted with resistant pulmonary oedema, a massively calcified aortic valve, renal failure and no transfemoral access option. How would you treat this patient?
Author
Author
Author
Author
PCRonline @ TCT 2023 - Get the international perspective!
17 Oct 2023
Thanks to the contribution of our team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science to be released at TCT 2023 - check out the list here!
Essentials of lifetime management in patient undergoing TAVI using novel balloon expandable Myval Octacor THV
22 Sep 2023 – From AICT-AsiaPCR 2023
This session with a LIVE case provides information about the Octacor transcatheter heart valve technology, highlighting its procedural and clinical benefits. It also covers the Octalign technique, which ensures precise alignment of commissural and coronary access, and discusses the precise sizing, positioning, and deployment of Octacor THV.
Innovations in TAVI and mitral interventions
22 Sep 2023 – From AICT-AsiaPCR 2023
Discover the latest advancements in TAVI and mitral interventions in this session: discover strategies for managing non-operable cases involving triple vessel disease and severe mitral regurgitation, along with insights into tackling recurrent heart failure in patients with coronary artery and valvular heart disease, delve into the...
Percutaneous treatment of pure aortic regurgitation: a new indication
21 Sep 2023 – From AICT-AsiaPCR 2023
Analyse the case of an 83-year-old male patient with history of HT, parkinson's disease and minor stroke, who presented with worsening exertional SOB, LVEF 55-60 %, dilated LV, mild MR, and severe AR, and study the different options to treat aortic regurgitation.
Valve-in-valve - LIVE case
21 Sep 2023 – From AICT-AsiaPCR 2023
An 84-year-old man, with a history of 23 Carpentier-Edwards in 2004, PPM in 2013, AF on warfarin and impaired LV function (40 %), presented with severe symptomatic stenosis of the surgical bioprosthesis.
A 23 Navitor was implanted without predilatation and with post-dilatation under cerebral protection (Sentinel).
Closure was...
Top abstracts of AICT-AsiaPCR 2023
21 Sep 2023 – From AICT-AsiaPCR 2023
Explore the cutting-edge research showcased in the top abstracts of AICT-AsiaPCR 2023, featuring insights on CT-based valve sizing for TAVR in bicuspid aortic stenosis and the impact of bleeding events post-TAVI on long-term mortality.
Coronary, structural and peripheral interventions
21 Sep 2023 – From AICT-AsiaPCR 2023
Explore the latest innovations in coronary, structural, and peripheral interventions in this session, from machine learning CT-FFR systems for severe aortic stenosis to the role of real-world data in enhancing cardiovascular care, and discover cutting-edge techniques like transpedal accesses for complex lesions and comprehensive valve sizing...
TAVI Insights: Addressing challenges and complex cases
21 Sep 2023 – From AICT-AsiaPCR 2023
In this session, explore the complexities of TAVR complications and learn about unique cases, including TAVI in patients with bicuspid aortic valves, coarctation of the aorta, and small annuli.
Top cases of AICT-AsiaPCR 2023
21 Sep 2023 – From AICT-AsiaPCR 2023
Discover the most intriguing cases featured at AICT-AsiaPCR 2023 in this session: from adrenaline surges to complex primary PCIs gone haywire, from CHIP protected PCI in AMICS to complex CTO of an anomalous RCA, dive into these real-world cases and gain valuable insights that expand your...
Commissural alignment during TAVI
13 Sep 2023
As lifetime management of aortic valve disease patients undergoing TAVI is gaining increased attention, this article sought to summarize the principal idea and possible technical implementation of commissural alignment with current generation transcatheter heart valves (THVs).
Author
Author
Author
PCRonline @ ESC Congress 2023: the interventional cardiology perspective!
07 Aug 2023
What was new and hot in interventional cardiology at #ESCCongress 2023!
Native TAVI in small annulus with low coronary take-off - Lifetime management
27 Jul 2023
Analyze the case of this 78-year-old female patient with diabetes, obesity, HTN and hyperlipidemia, who presented with severe symptomatic AS, severely calcified posterior mitral leaflet, and both mild mitral and tricuspid regurgitations, and tell us how you would treat this woman!
Author
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation
24 Jul 2023
The aim of the REVASC-TAVI study was to compare different PCI timing strategies in patients with AS and significant CAD undergoing TAVI.
Reviewer
Reviewer
2023 ESC Guidelines for the management of Endocarditis
24 Jul 2023
These guidelines have been developed to support healthcare professionals with the diagnosis and management of patients with infective endocarditis.
Alex Sticchi interviews Victoria Delgado on the updated version which she presented during the ESC Congress 2023 in Amsterdam: Discover the key elements and take-home messages.
Author
Author
NOTION 10 years - The nordic aortic valve intervention trial
28 Aug 2023
Luigi Biasco interviews Troels Højsgaard Jørgensen regarding the 10-year results of the NOTION trial which he presented at the ESC Congress 2023 in Amsterdam.
What can you learn about valve durability and life expectancy?
Author
Author
Evolution and prognostic impact of right ventricular–pulmonary artery coupling after transcatheter aortic valve replacement
19 Jul 2023
The aim of this study was to comprehensively assess the prognostic impact of TAPSE/PASP and its longitudinal variation in AS patients undergoing TAVR.
Reviewer
Reviewer
Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock
03 Jul 2023
This is the largest real world observational data that confirms the safety and efficacy of TAVR for the treatment of patients with severe aortic stenosis presenting with cardiogenic shock.
Reviewer
Reviewer
TAVI with the Evolut platform for bicuspid aortic valve stenosis: the international, multicentre, prospective BIVOLUTX registry
22 Jun 2023
The single-arm BIVOLUTX registry provides an accurate picture of contemporary practice and clinical outcomes of TAVI in BAV patients with AS, adding valuable prospective evidence to the field.
Reviewer
Reviewer
Why should we consider Bioprosthetic Valve Dysfunction for aortic valve selection?
Performing a high-volume of TAVI implantation, Chris Malkin (UK) shares experience and comments on the new concept of Bioprosthetic Valve Dysfunction with insights from the CoreValve-Evolut 5-year pooled analysis. What does Bioprosthetic Valve Dysfunction (BVD) mean according to the VARC 3 guidelines? What are the clinical...
